Joel P. Berger

15.6k total citations · 5 hit papers
93 papers, 11.8k citations indexed

About

Joel P. Berger is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Joel P. Berger has authored 93 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 47 papers in Physiology and 19 papers in Epidemiology. Recurrent topics in Joel P. Berger's work include Peroxisome Proliferator-Activated Receptors (61 papers), Adipose Tissue and Metabolism (44 papers) and Metabolism, Diabetes, and Cancer (28 papers). Joel P. Berger is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (61 papers), Adipose Tissue and Metabolism (44 papers) and Metabolism, Diabetes, and Cancer (28 papers). Joel P. Berger collaborates with scholars based in United States, Canada and Japan. Joel P. Berger's co-authors include David E. Moller, Taro E. Akiyama, Peter T. Meinke, Alex Elbrecht, Philipp E. Scherer, John A. Wagner, Karen L. MacNaul, Tom Doebber, Michael W. Rajala and Margaret Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Joel P. Berger

93 papers receiving 11.5k citations

Hit Papers

The Mechanisms of Action of PPARs 2002 2026 2010 2018 2002 2004 2006 2004 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Mechanisms of Action of PPARs
    2002 2.1k citations Joel P. Berger, David E. Moller profile →
  2. Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
    2004 978 citations Tom Doebber, Joel P. Berger et al. Journal of Biological Chemistry profile →
  3. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
    2006 813 citations Joel P. Berger, Jorge Plutzky et al. profile →
  4. Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells
    2004 647 citations Qiang Tian, Mao Mao et al. Molecular & Cellular Proteomics profile →
  5. PPARs: therapeutic targets for metabolic disease
    2005 587 citations Joel P. Berger, Taro E. Akiyama et al. profile →

Peers

Joel P. Berger
Manuel Vázquez‐Carrera Spain
David Bernlohr United States
Rolf K. Berge Norway
Lluís Fajas France
Toshifumi Aoyama Japan
Scott A. Summers United States
Odile D. Peroni United States
Jeffrey M. Peters United States
Youfei Guan China
Steven M. Watkins United States
Manuel Vázquez‐Carrera Spain
Joel P. Berger
Citations per year, relative to Joel P. Berger Joel P. Berger (= 1×) peers Manuel Vázquez‐Carrera

Countries citing papers authored by Joel P. Berger

Since Specialization
Citations

This map shows the geographic impact of Joel P. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel P. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel P. Berger more than expected).

Fields of papers citing papers by Joel P. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel P. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel P. Berger. The network helps show where Joel P. Berger may publish in the future.

Co-authorship network of co-authors of Joel P. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Joel P. Berger. A scholar is included among the top collaborators of Joel P. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel P. Berger. Joel P. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eiki, Jun‐ichi, Yasufumi Nagata, Mayumi Futamura, et al.. (2011). Pharmacokinetic and Pharmacodynamic Properties of the Glucokinase Activator MK-0941 in Rodent Models of Type 2 Diabetes and Healthy Dogs. Molecular Pharmacology. 80(6). 1156–1165. 25 indexed citations
3.
Tang, Haifeng, Zhe Feng, Lihu Yang, et al.. (2010). Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities. Bioorganic & Medicinal Chemistry Letters. 20(20). 6088–6092. 13 indexed citations
4.
Landskroner-Eiger, Shira, Bin‐Zhi Qian, Eric S. Muise, et al.. (2009). Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo. Clinical Cancer Research. 15(10). 3265–3276. 122 indexed citations
5.
Zhou, Heather, Chen‐Ni Chin, Margaret Wu, et al.. (2009). Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. European Journal of Pharmacology. 616(1-3). 346–352. 28 indexed citations
6.
Berthiaume, Magalie, Mathieu Laplante, William T. Festuccia, et al.. (2009). Preliminary report: pharmacologic 11β-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet. Metabolism. 59(1). 114–117. 15 indexed citations
7.
Shen, Hong C., Fa‐Xiang Ding, Qiaolin Deng, et al.. (2009). Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(18). 5314–5320. 22 indexed citations
8.
Muise, Eric S., B. Azzolina, Mohamed El-Sherbeini, et al.. (2008). Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic States. Molecular Pharmacology. 74(2). 403–412. 245 indexed citations
9.
Dropinski, James F., Taro E. Akiyama, Monica Einstein, et al.. (2005). Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5035–5038. 56 indexed citations
10.
Koyama, Hiroo, Daniel J. Miller, Joel P. Berger, et al.. (2005). (2R)-2-Methylchromane-2-carboxylic acids: Discovery of selective PPARα agonists as hypolipidemic agents. Bioorganic & Medicinal Chemistry Letters. 15(14). 3347–3351. 15 indexed citations
11.
Akiyama, Taro E., Peter T. Meinke, & Joel P. Berger. (2005). PPAR ligands: Potential therapies for metabolic syndrome. Current Diabetes Reports. 5(1). 45–52. 46 indexed citations
12.
Tian, Qiang, Mao Mao, Michelle J. Doyle, et al.. (2004). Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells. Molecular & Cellular Proteomics. 3(10). 960–969. 647 indexed citations breakdown →
13.
Thompson, G M, et al.. (2004). A high-capacity assay for PPARγ ligand regulation of endogenous aP2 expression in 3T3-L1 cells. Analytical Biochemistry. 330(1). 21–28. 40 indexed citations
14.
Doebber, Thomas W., Linda Kelly, Gaochao Zhou, et al.. (2004). MK-0767, a novel dual PPARα/γ agonist, displays robust antihyperglycemic and hypolipidemic activities. Biochemical and Biophysical Research Communications. 318(2). 323–328. 26 indexed citations
15.
Desai, Ranjit C., Hiroo Koyama, E. Joseph Metzger, et al.. (2003). Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3541–3544. 18 indexed citations
16.
Ziouzenkova, Ouliana, Liana Asatryan, Gabriela Orasanu, et al.. (2003). Dual Roles for Lipolysis and Oxidation in Peroxisome Proliferation-Activator Receptor Responses to Electronegative Low Density Lipoprotein. Journal of Biological Chemistry. 278(41). 39874–39881. 52 indexed citations
17.
Thieringer, Rolf, Judy Fenyk‐Melody, Patricia A. Detmers, et al.. (2000). Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo. The Journal of Immunology. 164(2). 1046–1054. 170 indexed citations
18.
Zhang, Bei, Karen L. MacNaul, Deborah Szalkowski, et al.. (1999). Inhibition of Adipocyte Differentiation by HIV Protease Inhibitors. The Journal of Clinical Endocrinology & Metabolism. 84(11). 4274–4277. 134 indexed citations
19.
Elbrecht, Alex, Yuli Chen, Alan Adams, et al.. (1999). L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ. Journal of Biological Chemistry. 274(12). 7913–7922. 92 indexed citations
20.
Haslanger, Martin F., Edmund J. Sybertz, Bernard R. Neustadt, et al.. (1989). Carboxyalkyl dipeptides with atrial natriuretic factor potentiating and antihypertensive activity. Journal of Medicinal Chemistry. 32(4). 737–739. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Vázquez‐Carrera Breakdown of academic impact, for papers by David Bernlohr Breakdown of academic impact, for papers by Rolf K. Berge Breakdown of academic impact, for papers by Lluís Fajas Breakdown of academic impact, for papers by Toshifumi Aoyama Breakdown of academic impact, for papers by Scott A. Summers Breakdown of academic impact, for papers by Odile D. Peroni Breakdown of academic impact, for papers by Jeffrey M. Peters Breakdown of academic impact, for papers by Youfei Guan Breakdown of academic impact, for papers by Steven M. Watkins
Rankless by CCL
2026